首页> 外国专利> Process, useful e.g. to prepare isolated 5-(N-2,3-dihydroxypropylacetamido)-2,4,6-triiodo-N-(2,3-dihydroxyethyl)-isophthalamide compound as active principle for non-ionic X-ray imaging, comprises atomization of an ioxilan aqueous solution

Process, useful e.g. to prepare isolated 5-(N-2,3-dihydroxypropylacetamido)-2,4,6-triiodo-N-(2,3-dihydroxyethyl)-isophthalamide compound as active principle for non-ionic X-ray imaging, comprises atomization of an ioxilan aqueous solution

机译:过程,有用的制备分离的5-(N-2,3-二羟丙基乙酰胺基)-2,4,6-三碘代-N-(2,3-二羟乙基)-间苯二酰胺化合物作为非离子X射线成像的活性成分,包括雾化ioxilan水溶液

摘要

Process for preparing an isolated 5-(N-2,3-dihydroxypropylacetamido)-2,4,6-triiodo-N-(2,3dihydroxyethyl)-isophtalamide compound (ioxilan) (I) comprises atomization of an ioxilan aqueous solution. Independent claims are included for: (1) a isolated ioxilan product obtained by the process and it has an instant solubility of at least 500 mg of iodine/mg and at a temperature of lower than 40[deg]C; and (2) a sterile injectable solution comprising (I) having 300-500 mg of iodine/ml, preferably 350-450 mg of iodine/ml.
机译:制备分离的5-(N-2,3-二羟丙基乙酰胺基)-2,4,6-三碘代-N-(2,3-二羟乙基)-异邻苯二酰胺化合物(ioxilan)的方法(I)包括将ioxilan水溶液雾化。包括以下独立权利要求:(1)通过该方法获得的分离的ioxilan产物,其在低于40℃的温度下具有至少500mg碘/ mg的即时溶解度; (2)无菌注射溶液,其包含(I)具有300-500mg / ml,优选350-450mg碘/ ml的碘。

著录项

  • 公开/公告号FR2899581A1

    专利类型

  • 公开/公告日2007-10-12

    原文格式PDF

  • 申请/专利权人 GUERBET SOCIETE ANONYME;

    申请/专利号FR20060003088

  • 发明设计人 PETTA MYRIAM;LAVERGNE DAMIEN;

    申请日2006-04-07

  • 分类号C07C231/12;A61K9/08;A61K49/04;

  • 国家 FR

  • 入库时间 2022-08-21 20:26:45

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号